Registry Platform Urologic Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced renal cell carcinoma or urothelial cancer in Germany.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta lub mężczyzna z zaawansowanym rakiem nerki lub pęcherza moczowego
- •Pacjent rozpoczynający pierwsze leczenie systemowe tego raka
- •Wiek co najmniej 18 lat
- •Wyrażenie pisemnej zgody na udział w badaniu
- •Dla pacjentów z rakiem pęcherza: pooperacyjna ocena guza wykazująca wysokie ryzyko nawrotu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Multiple sites, Germany
Multiple Locations, Germany
Trial contact
Michaela Koska
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.